✦ LIBER ✦

Exclusive mutation in epidermal growth factor receptor gene, HER-2, and KRAS, and synchronous methylation of nonsmall cell lung cancer

✍ Scribed by Makoto Suzuki; Hisayuki Shigematsu; Toshihiko Iizasa; Kenzo Hiroshima; Yukio Nakatani; John D. Minna; Adi F. Gazdar; Takehiko Fujisawa

Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 277 KB
Volume: 106
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.21853

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical significance of aberrant methyl

Clinical significance of aberrant methylation of prostaglandin E receptor 2 (PTGER2) in nonsmall cell lung cancer : Association with prognosis, PTGER2 expression, and epidermal growth factor receptor mutation

✍ Lei Tian; Makoto Suzuki; Takahiro Nakajima; Rieko Kubo; Yasuo Sekine; Kiyoshi Sh 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 193 KB 👁 2 views

Comparative analysis of epidermal growth

Comparative analysis of epidermal growth factor receptor mutations and gene amplification as predictors of gefitinib efficacy in Japanese patients with nonsmall cell lung cancer

✍ Takashi Sone; Kazuo Kasahara; Hideharu Kimura; Kazuto Nishio; Masayuki Mizuguchi 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 235 KB 👁 1 views

## Abstract ## BACKGROUND. Because the investigation of epidermal growth factor receptor gene (__EGFR__) status as a predictor of gefitinib efficacy in Japanese patients has shown promise, the authors evaluated __EGFR__ mutations and gene amplification in biopsy specimens from Japanese patients wi

Accuracy of epidermal growth factor rece

Accuracy of epidermal growth factor receptor mutation analysis on the basis of small biopsy specimens in patients with nonsmall cell lung cancer

✍ Shiro Fujita; Tadashi Mio; Makoto Sonobe; Kiyofumi Kamiyama; Katsuhiro Masago; R 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 49 KB 👁 1 views

Dear Sir

Protein overexpression and gene amplific

Protein overexpression and gene amplification of epidermal growth factor receptor in nonsmall cell lung carcinomas : An immunohistochemical and fluorescence in situ hybridization study

✍ Shioto Suzuki; Yoh Dobashi; Hiroyuki Sakurai; Keiichi Nishikawa; Mitsuhiko Hanaw 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 211 KB 👁 1 views

Epidermal growth factor receptor mutatio

Epidermal growth factor receptor mutations in needle biopsy/aspiration samples predict response to gefitinib therapy and survival of patients with advanced nonsmall cell lung cancer

✍ Jin-Yuan Shih; Chien-Hung Gow; Chong-Jen Yu; Chih-Hsin Yang; Yih-Leong Chang; Me 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 161 KB 👁 1 views

## Abstract Recently, mutations in the __epidermal growth factor receptor__ (__EGFR__) gene in nonsmall cell lung cancer (NSCLC) patients were reported to correlate with gefitinib response. Less than 30% of NSCLC patients are surgically resectable; however, molecular analysis has to rely on nonsurg

Response to dual blockade of epidermal g

Response to dual blockade of epidermal growth factor receptor (EGFR) and cycloxygenase-2 in nonsmall cell lung cancer may be dependent on the EGFR mutational status of the tumor

✍ Shirish M. Gadgeel; Shadan Ali; Philip A. Philip; Fakhara Ahmed; Antoinette Wozn 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 332 KB 👁 1 views

## Abstract ## BACKGROUND. Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR‐TKIs) have demonstrated clinical benefit in patients with nonsmall cell lung cancer (NSCLC), particularly those with tumors that have EGFR‐TK domain mutations. Moreover, the EGFR and cyclooxygenase (COX)‐2